Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the
neuronal compartment, but includes strong interactions with immunological mechanisms in …

Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …

We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD)
involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 …

We sought to identify new susceptibility loci for Alzheimer's disease through a staged
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …

Background Immunisation of patients with Alzheimer's disease with full-length amyloid-β
peptide (Aβ 42 ) can clear amyloid plaques from the brain. Our aim was to assess the relation …

Microglia, the resident macrophages of the CNS, are exquisitely sensitive to brain injury and
disease, altering their morphology and phenotype to adopt a so-called activated state in …

Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

Amyloid-β peptide (Aβ) has a key role in the pathogenesis of Alzheimer disease (AD).
Immunization with Aβ in a transgenic mouse model of AD reduces both age-related accumulation …

Background Clinical trials have shown the benefits of cholinesterase inhibitors for the
treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits …

It is well known that systemic infections cause flare-ups of disease in individuals with asthma
and rheumatoid arthritis, and that relapses in multiple sclerosis can often be associated …